Quellis Biosciences, Inc. — Form D
Quellis Biosciences, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-01. Industry: Biotechnology.
Offering
- Filed: 2018-06-01
- Form: D
- Accession: 0001741691-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Investors: 1
- Date of first sale: 2018-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313711
Issuer
- Name: Quellis Biosciences, Inc.
- CIK: 0001741691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 203 CRESCENT STREET, WALTHAM, MA, 02453
- Phone: 919-949-8552
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Fred Callori | Director | Houston, TX |
| Chris Garabedian | Director | San Francisco, CA |
| Tomas Kiselak | Director | West Conshohocken, PA |
| Tomas Kiselak | Executive Officer | West Conshohocken, PA |
| Peter Harwin | Director | West Conshohocken, PA |
| Peter Harwin | Executive Officer | West Conshohocken, PA |
| Frederick Callori | Director | Philadephia, PA |
| Jonathan Violin | Director | Waltham, MA |
| Jonathan Violin | Executive Officer | Waltham, MA |
| Christopher Garabedian | Director | Waltham, MA |
Other filings by this issuer (3)
More